Page last updated: 2024-11-05

trapidil and Pulmonary Hypertension

trapidil has been researched along with Pulmonary Hypertension in 2 studies

Trapidil: A coronary vasodilator agent.

Research Excerpts

ExcerptRelevanceReference
"Trapidil has been described to improve the redox balance and cardiac conditions."1.48Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model. ( Belló-Klein, A; Carraro, CC; Colombo, R; da Rosa Araujo, AS; de Lima-Seolin, BG; Lacerda, DS; Poletto Bonetto, JH; Schenkel, PC; Teixeira, RB; Türck, P, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Türck, P1
Lacerda, DS1
Carraro, CC1
de Lima-Seolin, BG1
Teixeira, RB1
Poletto Bonetto, JH1
Colombo, R1
Schenkel, PC1
Belló-Klein, A1
da Rosa Araujo, AS1
Schauer, J1
Orschekowski, H1
Winkler, J1
Steiniger, L1

Other Studies

2 other studies available for trapidil and Pulmonary Hypertension

ArticleYear
Trapidil improves hemodynamic, echocardiographic and redox state parameters of right ventricle in monocrotaline-induced pulmonary arterial hypertension model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103

    Topics: Animals; Blood Pressure; Calcium; Cardiac Catheterization; Cardiomegaly; Disease Models, Animal; Ech

2018
[Modification of pulmonary hypertension in patients with chronic obstructive lung diseases by trapidil (Rocornal) in an acute trial].
    Zeitschrift fur Erkrankungen der Atmungsorgane, 1991, Volume: 177, Issue:3

    Topics: Adult; Aged; Exercise Test; Female; Forced Expiratory Volume; Hemodynamics; Humans; Hypertension, Pu

1991